CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: We found that CP-CML CD34+ cells had a distinct splicing signature profile, suggesting: (i) a spliceosome deregulation from the diagnosis time and (ii) an intraclonal heterogeneity.